Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018

The statistic displays the quarterly share of Celltrion's Remsima in the European market from the first quarter of 2015 to the second quarter of 2018. As of Q2 2018, the Remsima products from South Korean biopharmaceutical company Celltrion took up around 54 percent within the European market, increased from 53 percent in the previous quarter.

Quarterly share of Celltrion's Remsima in the European market from 1st quarter 2015 to 2nd quarter 2018

Market share
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2018

Region

South Korea

Survey time period

Q1 2015 to Q2 2018

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.